Abiopharma

Asset Acquisitions and Disposals: PROPOSED DIVERSIFICATION OF THE GROUPS BUSINESS & DISPOSAL OF LIBRE HOSPITALITY LIMITED

Change - Announcement of Appointment: Appointment of Chief Financial Officer (Designate)

General Announcement: InnoTek Secures First Liquid Cooling Project, New Subsidiary to Support AI Infrastructure Expansion

ComEd Reaches 99% Restoration Following Multi-Day Severe Storm Event

CEL-SCI Corporation Announces Pricing of Offering

Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026

Asset Acquisitions and Disposals: Receipt of EMA Approval in relation to the Proposed Acquisition of an Additional 39% Interest in KMC

Oshkosh Defense Highlights Proven, Adaptable Tactical Mobility Solutions for Europe at Eurosatory 2026

Mirum Pharma - Mirum Pharmaceuticals and Incyte Announce Positive Pivotal Phase 2 Results from PROGRESS Study of Zilurgisertib in Fibrodysplasia Ossificans Progressiva

Mirum Pharmaceuticals and Incyte Announce Positive Pivotal Phase 2 Results from PROGRESS Study of Zilurgisertib in Fibrodysplasia Ossificans Progressiva